With great interest we have read the letter by Terriou and coworkers, who have performed
an extensive survey of CEBPA CpG promoter hypermethylation in T-ALL as well as in a …

Dear Editor, Myelofibrosis (MF) is the most severe form of myeloproliferative neoplasm
(MPN). Allogeneic hematopoietic stem cell transplantation (allo-HCT) is the only known …

Myelofibrosis and chronic myeloid leukemia (CML) are myeloproliferative disorders (MPD)
of hematopoietic stem cell and characterized by clonal neoplastic proliferation of one or …

In a recent issue of the journal, Makishima et al1 reported on the occurrence of mutations
typically associated with Philadelphiachromosome (Ph1) negative myeloproliferative (MPN) …

Two patients with a history of JAK2V617F polycythemia vera (PV) without a family history of
a myeloproliferative neoplasms developed chronic myeloid leukemia (CML) 12 and 18 …

Philadelphia chromosome–negative myeloproliferative neoplasms (MPNs), including
polycythemia vera, essential thrombocythemia (ET), and primary myelofibrosis, are clonal …

In this issue of Blood, Gallipoli et al show that combined targeting of BCR/ABL1 and Janus
kinase 2 (JAK2) by 2 established kinase inhibitors, nilotinib (NI) and the JAK1/2 kinase …

This report provided evidence for a strong donor Tcell–mediated graft-versus-myelofibrosis
effect. Adoptive immunotherapy for molecular residual disease monitored with highly …

Polycythemia vera (PV) and essential thrombocythemia (ET) are characterized by
JAK2V617F mutation in 95% and 60% of the patients, respectively. 1 Ruxolitinib is a …

To the Editor: A 42-year-old Chinese woman suffered from acute lymphoblastic leukemia
(ALL) with t (9; 22) and achieved complete remission with induction chemotherapy without …